Literature DB >> 29756996

TWSG1 Is a Novel Tumor Suppressor in Gastric Cancer.

Jingyi Yuan1, Jiali Zeng1, Chun Shuai2, Yue Liu3,4.   

Abstract

Gastric cancer has a high incidence and mortality in the world, especially in China. The pathogenesis leading to the high heterogeneity of gastric cancer remains unclear. It is believed that TWSG1 is associated with a variety of tumors, but there are few studies related to gastric cancer. To investigate the biological significance of TWSG1, we evaluated the TWSG1 expression of the clinical samples and gastric cancer cell lines (BGC-823, MGC-803, and SGC-790) via stomach cancer tissue array, real-time PCR, and western blotting. Then, we used CCK-8 and flow cytometry to detect the function and mechanism of TWSG1 in gastric cell lines. The analysis showed that TWSG1 showed decreased expression in clinical samples and BGC-823, MGC-803, and SGC-7901 cells. And, overexpressed TWSG1 inhibited the cell cycle and proliferation, TWSG1 might influence the proliferation of SGC-7901 and MGC-803 by regulating the BMP signaling. However, the influence of TWSG1 on BGC-823 cell is not associated with the BMP signaling. In conclusion, all of our findings revealed that TWSG1 maybe serves as a tumor suppressor gene in gastric cancer and potential biomarker or therapeutic target for the diagnosis and treatment of gastric cancer.

Entities:  

Keywords:  BMP signaling; TWSG1; gastric cancer

Mesh:

Substances:

Year:  2018        PMID: 29756996     DOI: 10.1089/dna.2018.4188

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  3 in total

1.  Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells.

Authors:  Chengmeng Jin; Xiaobing Zhu; Hao Wu; Yuqi Wang; Xun Hu
Journal:  J Biol Chem       Date:  2020-03-26       Impact factor: 5.157

2.  MicroRNA-34c-5p exhibits anticancer properties in gastric cancer by targeting MAP2K1 to inhibit cell proliferation, migration, and invasion.

Authors:  Qian Ma; Yuan Zhao; Zhaojun Li; Wenwei Gao; Yuanyi Xu; Bing Li; Yunning Huang; Zhenghao Huo
Journal:  Biomed Res Int       Date:  2022-09-27       Impact factor: 3.246

3.  Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.

Authors:  Xi Liu; Xiaodong Wei; Wei Niu; Dong Wang; Bo Wang; Hao Zhuang
Journal:  Mol Med Rep       Date:  2018-09-07       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.